NCT02978079 is a NA clinical trial of Automated pupillometry in Horner's Syndrome, sponsored by University of Zurich.

Who is sponsoring NCT02978079?

NCT02978079 is sponsored by University of Zurich.

What drugs are being tested in NCT02978079?

Interventions in NCT02978079: Automated pupillometry.

What condition does NCT02978079 study?

NCT02978079 studies Horner's Syndrome, Stroke, Dissection Carotid Artery.

Is NCT02978079 still recruiting?

NCT02978079 is currently status unknown. Last updated 11 January 2021.

Last reviewed 2021-01-11 · How we verify

NCT02978079

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Pupillometry in Horner's Syndrome

Status unknown NA Last updated 11 January 2021

What this trial tests

NA trial testing Automated pupillometry in Horner's Syndrome in 135 participants. Status unknown.

Timeline

15 February 2017

Primary endpoint
31 December 2021

31 December 2022

Quick facts

Lead sponsor	University of Zurich
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	diagnostic
Enrollment	135
Start date	15 February 2017
Primary completion	31 December 2021
Estimated completion	31 December 2022
Sites	1 location across Switzerland

Drugs / interventions tested

Automated pupillometry

Conditions studied

Horner's Syndrome — all drugs for Horner's Syndrome →
Stroke — all drugs for Stroke →
Dissection Carotid Artery — all drugs for Dissection Carotid Artery →

Sponsor

University of Zurich

Who can join

Adults 18 to 60, any sex, with Horner's Syndrome or Stroke. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Horner's syndrome (HS) is a result of interruption of the sympathetic innervation to the eye and ocular adnexa, which can occur due to carotid artery dissection (CAD), along which the sympathetic nerve fibers travel to reach the eye. Dissection of the carotid artery is one of the etiologies for ischemic stroke in young patients. In our current study, we will explore the diagnostic accuracy of automated binocular pupillometry in the diagnosis or HS, and its potential in identifying dissection of the carotid artery in patients of young age who suffer ischemic stroke.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other University of Zurich trials

Trials by the same sponsor.

NCT07485699 — Soy Processing and Food Allergy · NA · not yet recruiting
NCT07516912 — Evaluation of Free STI Testing Pilot Projects in Lucerne and Zurich, Switzerland · not yet recruiting
NCT07473115 — Individualized Analgesia in the Intensive Care Unit With a New Pain Assessment Bundle and Protocolized Analgesia Adjustm · not yet recruiting
NCT07524023 — Emotional-distress-based Integrated Care Programme in Patients With Stable COPD · NA · recruiting
NCT06481982 — Value of Advanced MRI Techniques in the Assessment of Endometriosis · withdrawn

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02978079 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Zurich
Last refreshed: 11 January 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02978079.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing